Clinical Trial Update: Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC [Phase 3]

View source ↗

Summary

Phase 3 trial update comparing sorafenib alone versus sorafenib in combination with low-dose FP in patients with advanced hepatocellular carcinoma; current stat…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• CISPLATIN (cisplatin)
• Sorafenib (Sorafenib)

Snippet

Sponsor: Ministry of Health, Labour and Welfare, Japan | Conditions: Advanced Hepatocellular Carcinoma, Carcinoma | Phase 3 | Status: UNKNOWN